Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Foon

Showing results (61-70 of 184) with videos related to

Pageof 19
Sort By:
Current Opinion in Molecular Therapeutics|March 16, 2001
The anti-idiotype vaccines for immunotherapyM Bhattacharya-Chatterjee, S K Chatterjee, K A Foon
Annals of Internal Medicine|October 1, 1990
Chronic lymphocytic leukemia: new insights into biology and therapyK A Foon, K R Rai, R P Gale
The New England Journal of Medicine|July 2, 1981
The antigenic characteristics of hematopoietic stem cellsJ H Fitchen, K A Foon, M J Cline
Cancer|February 1, 1987
Current and future uses of recombinant interferon alpha in the treatment of low-grade non-Hodgkin's lymphomaR G Steis, K A Foon, D L Longo
Cancer Chemotherapy and Biological Response Modifiers|November 1, 2001
Tumor associated antigen (TAA) mimicry and immunotherapy of malignant diseases from anti-idiotypic antibodies to peptide mimicsX Wang, W Luo, K A Foon, et al.
Blood|June 15, 1990
Interferon gamma augments Lym-1-dependent, granulocyte-mediated tumor cell lysisL Vaickus, W Biddle, D Cemerlić, et al.
Cancer|February 1, 1987
Interferon therapy of non-Hodgkin's lymphomaK A Foon, M S Roth, P A Bunn
Clinical and Experimental Immunology|July 1, 1982
The immunological classification of leukaemia based on a rapid microcytotoxicity testR J Billing, K A Foon, M Linker-Israeli
Seminars in Oncology|September 1, 1986
Alpha interferon treatment of low-grade B-cell non-Hodgkin's lymphomas, cutaneous T-cell lymphomas, and chronic lymphocytic leukemiaK A Foon, M S Roth, P A Bunn
Blood|July 1, 1982
Surface markers on leukemia and lymphoma cells: recent advancesK A Foon, R W Schroff, R P Gale
Pageof 19

Showing results (61-70 of 184) with videos related to

Sort By:
Pageof 19
Current Opinion in Molecular Therapeutics|March 16, 2001
The anti-idiotype vaccines for immunotherapyM Bhattacharya-Chatterjee, S K Chatterjee, K A Foon
Annals of Internal Medicine|October 1, 1990
Chronic lymphocytic leukemia: new insights into biology and therapyK A Foon, K R Rai, R P Gale
The New England Journal of Medicine|July 2, 1981
The antigenic characteristics of hematopoietic stem cellsJ H Fitchen, K A Foon, M J Cline
Cancer|February 1, 1987
Current and future uses of recombinant interferon alpha in the treatment of low-grade non-Hodgkin's lymphomaR G Steis, K A Foon, D L Longo
Cancer Chemotherapy and Biological Response Modifiers|November 1, 2001
Tumor associated antigen (TAA) mimicry and immunotherapy of malignant diseases from anti-idiotypic antibodies to peptide mimicsX Wang, W Luo, K A Foon, et al.
Blood|June 15, 1990
Interferon gamma augments Lym-1-dependent, granulocyte-mediated tumor cell lysisL Vaickus, W Biddle, D Cemerlić, et al.
Cancer|February 1, 1987
Interferon therapy of non-Hodgkin's lymphomaK A Foon, M S Roth, P A Bunn
Clinical and Experimental Immunology|July 1, 1982
The immunological classification of leukaemia based on a rapid microcytotoxicity testR J Billing, K A Foon, M Linker-Israeli
Seminars in Oncology|September 1, 1986
Alpha interferon treatment of low-grade B-cell non-Hodgkin's lymphomas, cutaneous T-cell lymphomas, and chronic lymphocytic leukemiaK A Foon, M S Roth, P A Bunn
Blood|July 1, 1982
Surface markers on leukemia and lymphoma cells: recent advancesK A Foon, R W Schroff, R P Gale
Pageof 19